Plotting a New Course in Multiple Myeloma
For some patients with myeloma, new targeted drugs may be an alternative to stem cell transplant.
Recognizing Side Effects in Novel Treatments for CLL Can Be Crucial
Patients taking novel treatments for CLL, and their caregivers, should know which side effects to expect — and recognize when they become emergencies.
Some Pediatric Regimens Can Be Successful in Adults With ALL
A study of acute lymphoblastic leukemia across the age spectrum is showing that some pediatric regimens can be successful in adults.
Patient-Reported Outcomes and Quality-of-Life Measures in Myeloid Disease Can Help Inform Treatment Decisions
Two posters presented at the annual meeting of the American Society of Hematology discussed patient-reported outcome measures and quality-of-life indicators as supportive tools for treatment in individuals being treated for acute myeloid leukemia and myelodysplastic syndrome.
A New Lease on Life: Treatments Are Extending Life Expectancies for Patients With Multiple Myeloma
Four new drugs, and novel treatment combinations, are further extending life expectancy for patients with multiple myeloma.
Survivors of Young-Adult Hodgkin Lymphoma Not Getting All Recommended Checkups
Only 30 percent of survivors at high risk for cardiac damage adhered to long-term recommendations including an echocardiogram, electrocardiogram or multigated acquisition scan.
Medical Illustration: Multiple Myeloma
Multiple myeloma begins with a single precancerous plasma cell that multiplies uncontrollably and can eventually cause bone lesions and anemia.
When Less Is More: Paring Down Treatment for Hodgkin Lymphoma May Reduce the Risk of Long-Term Side Effects
Paring down treatment for Hodgkin lymphoma may reduce the risk of long-term side effects. Minimizing without hurting cure rates is the challenge.
Keeping Advocacy at the Forefront
Inspired by Those in its Pages, CURE Hosts Events That Highlight, Bolster the Work of Patient Advocates
2 Clarke Drive Cranbury, NJ 08512